1. Home
  2. CRMD

CRMD

CorMedix Inc.

Logo CorMedix Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Founded: 2006 Country:
United States
United States
Employees: N/A City: BERKELEY HEIGHTS
Market Cap: 261.2M IPO Year: 2010
Target Price: $13.00 AVG Volume (30 days): 501.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.91 EPS Growth: N/A
52 Week Low/High: $2.57 - $6.89 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 225.63%

Share on Social Networks: